PACIRA PHARMACEUTICALS INC has a total of 106 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 1996. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, chemical engineering and medical technology are Oakwood Laboratories LLC, ZIGONG LAIDEMAN TECH CO LTD and JIANGSU PENGYAO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 28 | |
#2 | EPO (European Patent Office) | 20 | |
#3 | Japan | 13 | |
#4 | China | 10 | |
#5 | Hong Kong | 8 | |
#6 | Australia | 7 | |
#7 | Israel | 7 | |
#8 | WIPO (World Intellectual Property Organization) | 7 | |
#9 | Norway | 3 | |
#10 | Canada | 2 | |
#11 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Packaging and shipping | |
#6 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Mixing | |
#4 | Separation | |
#5 | Chemical or physical processes | |
#6 | Syringes | |
#7 | Unspecified technologies | |
#8 | Transport or storage devices | |
#9 | Microorganisms | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Schutt Ernest George | 34 |
#2 | Los Kathleen D A | 33 |
#3 | Mcguire Ronald Warren | 30 |
#4 | Walters Peter Andrew | 30 |
#5 | Garcia Louie Daniel | 21 |
#6 | Zhu Liangjin | 17 |
#7 | Kim Sinil | 12 |
#8 | Kim Taehee | 11 |
#9 | Lambert William Joseph | 10 |
#10 | Kharitonov Vladimir | 9 |
Publication | Filing date | Title |
---|---|---|
WO2021011299A1 | Multivesicular liposome formulations of dexmedetomidine | |
CN109983013A | Meloxicam zinc complexes particle multivesicular liposome preparation and preparation method thereof | |
US2016206580A1 | Multivesicular liposome formulations of tranexamic acid | |
AU2015200303A1 | Production of multivesicular liposomes | |
AU2012203661A1 | Production of multivesicular liposomes | |
EP2632553A1 | A sustained release formulation of a non-steroidal anti-inflammatory drug | |
WO2011143484A1 | A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent | |
CN104922071A | Method for formulating large diameter synthetic membrane vesicles | |
US2010305500A1 | Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent | |
JP2009067771A | Therapeutic method for neurological disease | |
AU2002322024B2 | Encapsulation of nanosuspensions in liposomes and microspheres |